Home/Filings/4/0001822629-24-000008
4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-24-000008

CIK 0001023024other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:09 PM ET

Size

5.1 KB

Accession

0001822629-24-000008

Insider Transaction Report

Form 4
Period: 2024-03-23
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
  • Tax Payment

    Common Stock

    2024-03-23$69.58/sh17,455$1,214,519394,174 total
Footnotes (1)
  • [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001822629

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:09 PM ET
Size
5.1 KB